Alam M
Bioinformation. 2022; 18(3):310-317.
PMID: 36518138
PMC: 9722439.
DOI: 10.6026/97320630018310.
Wang P, Liu D, Yan S, Cui J, Liang Y, Ren S
Toxics. 2022; 10(5).
PMID: 35622678
PMC: 9144769.
DOI: 10.3390/toxics10050265.
Lee M, Lee J, Kim W, Kim S, Kim S, Kim H
Int J Mol Sci. 2022; 23(9).
PMID: 35563168
PMC: 9105847.
DOI: 10.3390/ijms23094778.
Xing Y, Wei X, Liu Y, Wang M, Sui Z, Wang X
Autophagy. 2021; 18(8):1932-1954.
PMID: 34878954
PMC: 9450983.
DOI: 10.1080/15548627.2021.2008752.
Marruecos L, Manils J, Moreta C, Gomez D, Filgaira I, Serafin A
Cell Death Dis. 2021; 12(4):359.
PMID: 33824284
PMC: 8024389.
DOI: 10.1038/s41419-021-03638-3.
Olaquindox-Induced Liver Damage Involved the Crosstalk of Oxidative Stress and p53 In Vivo and In Vitro.
Li D, Pei X, Qin X, Liu X, Li C, Li L
Oxid Med Cell Longev. 2020; 2020:8835207.
PMID: 33381272
PMC: 7762677.
DOI: 10.1155/2020/8835207.
Defenses against Pro-oxidant Forces - Maintenance of Cellular and Genomic Integrity and Longevity.
Murray D, Mirzayans R, McBride W
Radiat Res. 2018; 190(4):331-349.
PMID: 30040046
PMC: 6203329.
DOI: 10.1667/RR15101.1.
Microenvironment-Cell Nucleus Relationship in the Context of Oxidative Stress.
Chittiboyina S, Bai Y, Lelievre S
Front Cell Dev Biol. 2018; 6:23.
PMID: 29594114
PMC: 5854663.
DOI: 10.3389/fcell.2018.00023.
Li-Fraumeni Syndrome Disease Model: A Platform to Develop Precision Cancer Therapy Targeting Oncogenic p53.
Zhou R, Xu A, Gingold J, Strong L, Zhao R, Lee D
Trends Pharmacol Sci. 2017; 38(10):908-927.
PMID: 28818333
PMC: 5752137.
DOI: 10.1016/j.tips.2017.07.004.
The Role of Catalase C262T Gene Polymorphism in the Susceptibility and Survival of Cancers.
Wang C, Sun Y, Chen N, Huang L, Huang J, Zhu M
Sci Rep. 2016; 6:26973.
PMID: 27225983
PMC: 4880922.
DOI: 10.1038/srep26973.
Augmentation of oxidative stress-induced apoptosis in MCF7 cells by ascorbate-tamoxifen and/or ascorbate-juglone treatments.
Sajadimajd S, Yazdanparast R, Roshanzamir F
In Vitro Cell Dev Biol Anim. 2015; 52(2):193-203.
PMID: 26559067
DOI: 10.1007/s11626-015-9961-4.
Genetic networks lead and follow tumor development: microRNA regulation of cell cycle and apoptosis in the p53 pathways.
Otsuka K, Ochiya T
Biomed Res Int. 2014; 2014:749724.
PMID: 25302307
PMC: 4180389.
DOI: 10.1155/2014/749724.
p53 as a retrovirus-induced oxidative stress modulator.
Kim S, Wong P
J Gen Virol. 2014; 96(Pt 1):144-149.
PMID: 25252686
PMC: 4268820.
DOI: 10.1099/vir.0.070391-0.
The anti-hypercholesterolemic effect of low p53 expression protects vascular endothelial function in mice.
Leblond F, Poirier S, Yu C, Duquette N, Mayer G, Thorin E
PLoS One. 2014; 9(3):e92394.
PMID: 24647794
PMC: 3960235.
DOI: 10.1371/journal.pone.0092394.
Regulation of pyruvate metabolism in metabolic-related diseases.
Jeoung N, Harris C, Harris R
Rev Endocr Metab Disord. 2013; 15(1):99-110.
PMID: 24214243
DOI: 10.1007/s11154-013-9284-2.
Inflammation and insulin resistance exert dual effects on adipose tissue tumor protein 53 expression.
Ortega F, Moreno-Navarrete J, Mayas D, Serino M, Rodriguez-Hermosa J, Ricart W
Int J Obes (Lond). 2013; 38(5):737-45.
PMID: 23999197
DOI: 10.1038/ijo.2013.163.
Oxidative damage and carcinogenesis.
Strzelczyk J, Wiczkowski A
Contemp Oncol (Pozn). 2013; 16(3):230-3.
PMID: 23788885
PMC: 3687415.
DOI: 10.5114/wo.2012.29290.
"Super p53" mice display retinal astroglial changes.
Salazar J, Gallego-Pinazo R, de Hoz R, Pinazo-Duran M, Rojas B, Ramirez A
PLoS One. 2013; 8(6):e65446.
PMID: 23762373
PMC: 3676457.
DOI: 10.1371/journal.pone.0065446.
Drug-induced oxidative stress and toxicity.
Deavall D, Martin E, Horner J, Roberts R
J Toxicol. 2012; 2012:645460.
PMID: 22919381
PMC: 3420138.
DOI: 10.1155/2012/645460.
Proline dehydrogenase (oxidase) in cancer.
Liu W, Phang J
Biofactors. 2012; 38(6):398-406.
PMID: 22886911
PMC: 7479541.
DOI: 10.1002/biof.1036.
